Short-sighted push-up sales practice to hit pharmaceutical firms

There are mounting voices in the local pharmaceutical industry that Korean drug makers will no longer be dependent on ‘forced sales’ of OTC products to achieve their sales target.

Market experts pointed out that such common business practice will weaken the company’s financial stability in the long run.

They said the unilateral push-up sales policy will cause massive stockpile of drugs an...